Central Nervous System (CNS) Therapeutic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065136
  • May 2021
  • Pharmaceuticals
  • 142 Pages
The Central Nervous System (CNS) Therapeutic market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Central Nervous System (CNS) Therapeutic market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Eli Lilly and Company, Pfizer Inc., Otsuka America Pharmaceutical, Inc., Biogen, Merck & Co., Inc., AstraZeneca, Novartis AG, Shire (Takeda), Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Central Nervous System (CNS) Therapeutic market along with their effects over the forecast period. Similarly, according to the region Central Nervous System (CNS) Therapeutic market research report includes the study of opportunities available in the market situation.

The Central Nervous System (CNS) Therapeutic market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Central Nervous System (CNS) Therapeutic Market:
The Central Nervous System (CNS) Therapeutic market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Eli Lilly and Company, Pfizer Inc., Otsuka America Pharmaceutical, Inc., Biogen, Merck & Co., Inc., AstraZeneca, Novartis AG, Shire (Takeda), Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc.

Central Nervous System (CNS) Therapeutic Market Segmentation Analysis:
by Disease Type
Neurovascular Diseases
Degenerative Disorders
Mental Health
Trauma
Others
Drug Type
Analgesics
Nervous System Drugs
Anesthetics
Anti-Parkinson Drugs
Anti-Epileptics
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies

Global Central Nervous System (CNS) Therapeutic Market Segmentation by Regions:
In regional analysis, Central Nervous System (CNS) Therapeutic market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Central Nervous System (CNS) Therapeutic market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Central Nervous System (CNS) Therapeutic Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Central Nervous System (CNS) Therapeutic Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Central Nervous System (CNS) Therapeutic Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Central Nervous System (CNS) Therapeutic Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Central Nervous System (CNS) Therapeutic Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Central Nervous System (CNS) Therapeutic market, according to the key region.
  • To study the Central Nervous System (CNS) Therapeutic market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Central Nervous System (CNS) Therapeutic market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Central Nervous System (CNS) Therapeutic research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Central Nervous System (CNS) Therapeutic market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Central Nervous System (CNS) Therapeutic market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Central Nervous System (CNS) Therapeutic market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Central Nervous System (CNS) Therapeutic market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Central Nervous System (CNS) Therapeutic market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Eli Lilly and Company
  • Pfizer Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Biogen
  • Merck & Co., Inc.
  • AstraZeneca
  • Novartis AG
  • Shire (Takeda)
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Services, Inc.
  • Neurovascular Diseases
  • Degenerative Disorders
  • Mental Health
  • Trauma
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Central Nervous System (CNS) Therapeutic Market Snapshot
          2.1.1. Global Central Nervous System (CNS) Therapeutic Market By Disease Type,2019
               2.1.1.1.Neurovascular Diseases
               2.1.1.2.Degenerative Disorders
               2.1.1.3.Mental Health
               2.1.1.4.Trauma
               2.1.1.5.Others
          2.1.2. Global Central Nervous System (CNS) Therapeutic Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
          2.1.3. Global Central Nervous System (CNS) Therapeutic Market By End-use,2019
          2.1.4. Global Central Nervous System (CNS) Therapeutic Market By Geography,2019

3. Global Central Nervous System (CNS) Therapeutic Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Disease Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Disease Type, 2020
     4.2. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028

5. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028

7. Global Central Nervous System (CNS) Therapeutic Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Central Nervous System (CNS) Therapeutic Market Analysis, 2018 – 2028 
          7.2.1. North America Central Nervous System (CNS) Therapeutic Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028
          7.2.3. North America Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Central Nervous System (CNS) Therapeutic Market Analysis, 2018 – 2028 
          7.3.1.  Europe Central Nervous System (CNS) Therapeutic Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028
          7.3.3. Europe Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Central Nervous System (CNS) Therapeutic Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Central Nervous System (CNS) Therapeutic Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028
          7.4.3. Asia Pacific Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Central Nervous System (CNS) Therapeutic Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Central Nervous System (CNS) Therapeutic Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028
          7.5.3. Latin America Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Central Nervous System (CNS) Therapeutic Market Analysis, 2018 – 2028 
          7.6.1.  MEA Central Nervous System (CNS) Therapeutic Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Central Nervous System (CNS) Therapeutic Market Size (US$), By Disease Type, 2018 – 2028
          7.6.3. MEA Central Nervous System (CNS) Therapeutic Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Central Nervous System (CNS) Therapeutic Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Central Nervous System (CNS) Therapeutic Providers
        8.4.1 Eli Lilly and Company
                8.4.1.1 Business Description
                8.4.1.2 Eli Lilly and Company Geographic Operations
                8.4.1.3 Eli Lilly and Company Financial Information
                8.4.1.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.1.5 Eli Lilly and Company Key Developments
        8.4.2 Pfizer Inc.
                8.4.2.1 Business Description
                8.4.2.2 Pfizer Inc. Geographic Operations
                8.4.2.3 Pfizer Inc. Financial Information
                8.4.2.4 Pfizer Inc. Product Positions/Portfolio
                8.4.2.5 Pfizer Inc. Key Developments
        8.4.3 Otsuka America Pharmaceutical, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Otsuka America Pharmaceutical, Inc. Geographic Operations
                8.4.3.3 Otsuka America Pharmaceutical, Inc. Financial Information
                8.4.3.4 Otsuka America Pharmaceutical, Inc. Product Positions/Portfolio
                8.4.3.5 Otsuka America Pharmaceutical, Inc. Key Developments
        8.4.4 Biogen
                8.4.4.1 Business Description
                8.4.4.2 Biogen Geographic Operations
                8.4.4.3 Biogen Financial Information
                8.4.4.4 Biogen Product Positions/Portfolio
                8.4.4.5 Biogen Key Developments
        8.4.5 Merck & Co., Inc.
                8.4.5.1 Business Description
                8.4.5.2 Merck & Co., Inc. Geographic Operations
                8.4.5.3 Merck & Co., Inc. Financial Information
                8.4.5.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.5.5 Merck & Co., Inc. Key Developments
        8.4.6 AstraZeneca
                8.4.6.1 Business Description
                8.4.6.2 AstraZeneca Geographic Operations
                8.4.6.3 AstraZeneca Financial Information
                8.4.6.4 AstraZeneca Product Positions/Portfolio
                8.4.6.5 AstraZeneca Key Developments
        8.4.7 Novartis AG
                8.4.7.1 Business Description
                8.4.7.2 Novartis AG Geographic Operations
                8.4.7.3 Novartis AG Financial Information
                8.4.7.4 Novartis AG Product Positions/Portfolio
                8.4.7.5 Novartis AG Key Developments
        8.4.8 Shire (Takeda)
                8.4.8.1 Business Description
                8.4.8.2 Shire (Takeda) Geographic Operations
                8.4.8.3 Shire (Takeda) Financial Information
                8.4.8.4 Shire (Takeda) Product Positions/Portfolio
                8.4.8.5 Shire (Takeda) Key Developments
        8.4.9 Teva Pharmaceutical Industries Ltd.
                8.4.9.1 Business Description
                8.4.9.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.9.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.9.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.9.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.10 Johnson & Johnson Services, Inc.
                8.4.10.1 Business Description
                8.4.10.2 Johnson & Johnson Services, Inc. Geographic Operations
                8.4.10.3 Johnson & Johnson Services, Inc. Financial Information
                8.4.10.4 Johnson & Johnson Services, Inc. Product Positions/Portfolio
                8.4.10.5 Johnson & Johnson Services, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Central Nervous System (CNS) Therapeutic Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Central Nervous System (CNS) Therapeutic Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Central Nervous System (CNS) Therapeutic Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Central Nervous System (CNS) Therapeutic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Central Nervous System (CNS) Therapeutic Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Central Nervous System (CNS) Therapeutic Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Central Nervous System (CNS) Therapeutic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Central Nervous System (CNS) Therapeutic Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Central Nervous System (CNS) Therapeutic Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Central Nervous System (CNS) Therapeutic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Central Nervous System (CNS) Therapeutic Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Central Nervous System (CNS) Therapeutic Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Central Nervous System (CNS) Therapeutic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Central Nervous System (CNS) Therapeutic Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Central Nervous System (CNS) Therapeutic Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Central Nervous System (CNS) Therapeutic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Central Nervous System (CNS) Therapeutic: Market Segmentation 
FIG. 2 Global Central Nervous System (CNS) Therapeutic Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Central Nervous System (CNS) Therapeutic Market, By Disease Type, 2019 (US$ Mn) 
FIG. 5 Global Central Nervous System (CNS) Therapeutic Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Central Nervous System (CNS) Therapeutic Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Central Nervous System (CNS) Therapeutic Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Central Nervous System (CNS) Therapeutic Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Central Nervous System (CNS) Therapeutic Providers, 2019
FIG. 11 Global Central Nervous System (CNS) Therapeutic Market Revenue Contribution, By Disease Type, 2019 & 2028 (Value %) 
FIG. 12 Global Central Nervous System (CNS) Therapeutic Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Central Nervous System (CNS) Therapeutic Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Central Nervous System (CNS) Therapeutic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Central Nervous System (CNS) Therapeutic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Central Nervous System (CNS) Therapeutic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Central Nervous System (CNS) Therapeutic Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Central Nervous System (CNS) Therapeutic Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Central Nervous System (CNS) Therapeutic market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Central Nervous System (CNS) Therapeutic Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Central Nervous System (CNS) Therapeutic Market Value, By Segment1, 2018 – 2028
TABLE  North America Central Nervous System (CNS) Therapeutic Market Value, By Segment2, 2018 – 2028
TABLE  North America Central Nervous System (CNS) Therapeutic Market Value, By Country, 2018 – 2028
TABLE  Europe Central Nervous System (CNS) Therapeutic Market Value, By Segment1, 2018 – 2028
TABLE  Europe Central Nervous System (CNS) Therapeutic Market Value, By Segment2, 2018 – 2028
TABLE  Europe Central Nervous System (CNS) Therapeutic Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Central Nervous System (CNS) Therapeutic Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Central Nervous System (CNS) Therapeutic Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Central Nervous System (CNS) Therapeutic Market Value, By Country, 2018 – 2028
TABLE  Latin America Central Nervous System (CNS) Therapeutic Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Central Nervous System (CNS) Therapeutic Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Central Nervous System (CNS) Therapeutic Market Value, By Country, 2018 – 2028
TABLE  MEA Central Nervous System (CNS) Therapeutic Market Value, By Segment1, 2018 – 2028
TABLE  MEA Central Nervous System (CNS) Therapeutic Market Value, By Segment2, 2018 – 2028
TABLE  MEA Central Nervous System (CNS) Therapeutic Market Value, By Country, 2018 – 2028
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Otsuka America Pharmaceutical, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biogen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shire (Takeda): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Services, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Central Nervous System (CNS) Therapeutic Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Central Nervous System (CNS) Therapeutic Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Central Nervous System (CNS) Therapeutic Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Central Nervous System (CNS) Therapeutic Market, By Geography, 2019 (US$ Mn)
FIG.  Global Central Nervous System (CNS) Therapeutic Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Central Nervous System (CNS) Therapeutic Providers, 2016
FIG.  Global Central Nervous System (CNS) Therapeutic Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Degenerative Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Mental Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Trauma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Central Nervous System (CNS) Therapeutic Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Central Nervous System (CNS) Therapeutic Market Value, 2018 – 2028, (US$ Mn)